In this Thought Leaders in Health Law® video, John S. Linehan, Alan J. Arville, and Constance A. Wilkinson, attorneys in the Health Care and Life Sciences practice, discuss payment model changes, new regulatory approaches, and enforcement issues related to drug pricing and reimbursements.
This video examines the following:
- Innovation in the pharmaceutical industry that is influencing cost
- New outcomes-based pricing and government reimbursement models
- The use of government enforcement and scrutiny as a tool to manage cost
- The difficulty of creating robust drug pricing reform in the future
Epstein Becker Green works across multiple legal and regulatory fields to serve pharmaceutical companies. Learn more about the solutions and services that we provide.
About Thought Leaders in Health Law
The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.
Trouble viewing this video? Please contact Kelli Sakalousky at email@example.com and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.
THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.